Pay in 4 interest-free payments of $6.78 Learn more
Ships within 48 hours · Estimated delivery Nov 5 - Nov 10
Using them in sequence (lighter AHK-Cu spray first, followed by GHK-Curich creams or serums) allows each peptide to optimize a different aspect of skin biology
This product is intended for laboratory research use only, and researchers should follow appropriate safety protocols
By interfering with this survival pathway, FOXO4-DRI induces apoptosis specifically in senescent cells while leaving healthy cells unaffected
The antioxidant benefits remain valuable even with reduced sun exposure, pollution and indoor heating create their own oxidative stress
Patients who are already managing the once-weekly injection cadence of Semaglutide or Tirzepatide and do not want to add daily injections are not good candidates for GHK-Cu, not because of any contraindication, but because they wont maintain the protocol consistently enough to see results
